Your browser doesn't support javascript.
loading
Cereblon enhancer methylation and IMiD resistance in multiple myeloma.
Haertle, Larissa; Barrio, Santiago; Munawar, Umair; Han, Seungbin; Zhou, Xiang; Vogt, Cornelia; Fernández, Rafael Alonso; Bittrich, Max; Ruiz-Heredia, Yanira; Da Viá, Matteo; Zovko, Josip; Garitano-Trojaola, Andoni; Bolli, Niccolò; Ruckdeschel, Anna; Stühmer, Thorsten; Chatterjee, Manik; Kull, Miriam; Krönke, Jan; Agirre, Xabier; Martin-Subero, Jose I; Raab, Peter; Einsele, Hermann; Rasche, Leo; Martinez-Lopez, Joaquin; Haaf, Thomas; Kortüm, K Martin.
Afiliación
  • Haertle L; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Barrio S; Institute of Human Genetics, Julius Maximilian University of Würzburg, Würzburg, Germany.
  • Munawar U; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Han S; Altum Sequencing Co., Madrid, Spain.
  • Zhou X; Department of Hematology, Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center, Complutense University Madrid, Madrid, Spain.
  • Vogt C; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Fernández RA; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Bittrich M; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Ruiz-Heredia Y; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Da Viá M; Department of Hematology, Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center, Complutense University Madrid, Madrid, Spain.
  • Zovko J; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Garitano-Trojaola A; Altum Sequencing Co., Madrid, Spain.
  • Bolli N; Department of Hematology, Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center, Complutense University Madrid, Madrid, Spain.
  • Ruckdeschel A; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Stühmer T; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Chatterjee M; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Kull M; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Krönke J; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Agirre X; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Martin-Subero JI; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Raab P; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Einsele H; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Rasche L; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Martinez-Lopez J; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.
  • Haaf T; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.
  • Kortüm KM; Área de Hemato-Oncología, Centro de Investigación Médica Aplicada, Centro de Investigación Biomédica en Red-Cáncer (CIBERONC), Instituto de Investigación Sanitaria de Navarra, Universidad de Navarra, Pamplona, Spain.
Blood ; 138(18): 1721-1726, 2021 11 04.
Article en En | MEDLINE | ID: mdl-34115836
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ubiquitina-Proteína Ligasas / Proteínas Adaptadoras Transductoras de Señales / Antineoplásicos Inmunológicos / Agentes Inmunomoduladores / Mieloma Múltiple Límite: Humans Idioma: En Revista: Blood Año: 2021 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ubiquitina-Proteína Ligasas / Proteínas Adaptadoras Transductoras de Señales / Antineoplásicos Inmunológicos / Agentes Inmunomoduladores / Mieloma Múltiple Límite: Humans Idioma: En Revista: Blood Año: 2021 Tipo del documento: Article País de afiliación: Alemania